Evaluation of Phase II of the Medicare Advantage Value-Based Insurance Design Model Test

First Two Years of Implementation (2020–2021), and Appendixes

Published in: Centers for Medicare & Medicaid Services website (2022)

Posted on RAND.org on October 19, 2022

by Dmitry Khodyakov, Christine Eibner, Erin Audrey Taylor, Rebecca Anhang Price, Christine Buttorff, Matthew Cefalu, Brian G. Vegetabile, Julia Bandini, Monique Martineau, Catherine C. Cohen, et al.

Read More

Access further information on this document at innovation.cms.gov

This article was published outside of RAND. The full text of the article can be found at the link above.

This report presents the RAND Corporation team's findings from its evaluation of Phase II of the Medicare Advantage (MA) Value-Based Insurance Design (VBID) model test, initiated by the Center for Medicare & Medicaid Innovation (CMMI), for the years 2020 and 2021. VBID allows participating MA parent organizations (POs) to offer supplemental benefits and financial and nonfinancial incentives to beneficiaries, hospice benefits (an MA hospice benefit, palliative care, transitional current care, and hospice supplemental benefits), and wellness and health care planning (WHP) through their MA plans. Some benefits may be targeted to beneficiaries with certain chronic conditions, or based on beneficiaries' socioeconomic status measured by qualification for the Medicare Part D low-income subsidy (LIS) or by dual eligibility for Medicare and Medicaid in territories where LIS is not available. Other VBID benefits must be offered to all beneficiaries within a VBID plan.

In this report, we describe findings from interviews with representatives of both participating and nonparticipating POs, vendors, and in-network and out-of-network hospices. We also report initial findings on the estimated association between VBID and a variety of key outcomes for 2020 and 2021, given data availability. We analyze outcomes including beneficiary participation, enrollment, bids, premiums, and projected costs of supplemental benefits to the Centers for Medicare & Medicaid Services (CMS). A separate appendix provides additional information on research questions, primary data collection and analysis, statistical approach, and other material. The results will be useful to multiple audiences, such as policymakers, health plans, and researchers interested in insurance benefit design.

A separate appendix provides additional information on research questions, primary data collection and analysis, statistical approach, and other material.

Research conducted by

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.